Search News
| 112.23 Delayed Data As of Jun 22 |  -0.38 / -0.34%Today’s Change | 100.22 Today|||52-Week Range 119.30 | +5.11% Year-to-Date |
The investment seeks to track the investment results of the NASDAQ Biotechnology Index- which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq- Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures- options and swap contracts- cash and cash equivalents. It is non-diversified.
| Sarepta Pharma Pushes Two Biotech ETFs to New Highs Jun 20 / Zacks.com - Paid Partner Content |
| 1 month | +5.09% | 3 years | -4.05% | |
| 3 months | +3.86% | 5 years | +15.02% | |
| 1 year | +5.39% | Since inception | +7.39% |
| Previous close | $112.61 |
| Open day’s range | 111.69 – 112.88 |
| Net asset value (NAV) | 112.22 (06/22/2018) |
| Daily volume | 2,432,646 |
| Average volume (3 months) | 2,618,655 |
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +15.02% | +14.29% |
| Expense Gross exp ratio | 0.47% | 1.29% |
| Risk 5 year sharpe ratio | 0.63 | 0.90 |
| Net assets | $8.7B | $3.0B |
| Average market cap | $14.8B | $28.5B |
| Average P/E | 28.7 | 25.2 |
| Dividend / Share | -- | 0.30% |
| FHLC Fidelity® MSCI Health Care Index ETF |
| XLV Health Care Select Sector SPDR® Fund |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
| Holdings not available. |
